Table 3.
PSA range | 0.2–0.5 ng/ml (very low) | > 0.5–1.0 ng/ml (low) | p value | ||
---|---|---|---|---|---|
No. | % | No. | % | ||
Total no. of patients with positive findings | 89/151 | 58.9 | 112/141 | 79.4 | 0.0003* |
Localization of positive findings on 68Ga-PSMA-11-ligand PET | |||||
Local | 24/151 | 15.9 | 38/141 | 27.0 | 0.0297* |
LN pelvic/retroperitoneal | 58/151 | 38.4 | 73/141 | 51.8 | 0.0290* |
LN supradiaphragmal | 7/151 | 4.6 | 7/141 | 5.0 | 0.9091 |
Bone | 30/151 | 19.9 | 28/141 | 19.9 | 0.8834 |
Visceral | 2/151 | 1.3 | 4/141 | 2.8 | 0.6215 |
*Significant difference p ≤ 0.05